The inaugural Stanford Ophthalmology 2019 Annual Report, "Vision Matters" highlights the department's recent news and accomplishments. Click here to read or download the PDF.

Illustration by Alton Szeto, MFA, © 2019.


In this Issue

For image credits, view PDF

  • Invented at Stanford

    The Stanford Department of Ophthalmology has a rich history of innovation and academic accomplishment dating back more than 100 years.

  • One cell at a time

    Retinal cell death due to glaucoma, diabetic retinopathy, macular degeneration, and a myriad of other conditions leads to irreversible vision loss.

  • Creating a field of molecular surgery to guide new therapies

    A significant challenge for ophthalmologists is diagnosing diseases that appear clinically similar. Inside the eye, a “snowstorm” of white cells can be due to an autoimmune disease, cancer, or an infection, each requiring very different therapies.

  • Developing cures with stem cells and regenerative medicine

    Too many major eye diseases lead to loss of vision that, even with current medicine or surgery, is irreversible. In macular degeneration, glaucoma, and the major corneal diseases, the cells responsible for normal visual function die and are not replaced through natural healing mechanisms.